P766: CLINICAL OUTCOMES IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES RECEIVING HYPOMETHYLATING AGENTS: A LARGE POPULATION-BASED ANALYSIS
oleh: A. M. Zeidan, E. S. Mearns, C. Ng, A. Shah, N. Lamarre, A. Yellow-Duke, N. Alrawashdh, B. Yang, W. Cheng, C. N. Bui, A. Svensson
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2022-06-01 |
Deskripsi
No description available for this item.